Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05632653 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05632653 · ClinicalTrials.gov record · last posted 2024-09-19

CTO-PCI in Heart Failure Patients

Study acronym: CTO-HF
StatusNot Yet Recruiting
PhaseNot applicable
Started2025-09
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The study investigates wheather CTO-PCI improves survival and heart failure related rehospitalization compared to optimal medical therapy (OMT). This hypothesis will be investigated within a large-scaled international, representative, prospective, randomized, controlled, open-label, event-driven, multicentre trial (trial acronym: CTO - Heart Failure) recruiting patients with planned CTO-PCI.

Amendment record 1 amendment on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended once since 2022-11-21. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

Trial Details
NCT Number NCT05632653
Lead Sponsor Universitätsmedizin Mannheim
Collaborators: Herzzentrum Lahr, IHF GmbH - Institut für Herzinfarktforschung
Conditions Coronary Artery Disease, Chronic Total Occlusion, Heart Failure
Enrollment 783 participants
Start Date 2025-09
Primary Completion 2030-03 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2024-09-19